F.D.A. Approves New Treatment for Early Alzheimer’s

F.D.A. Approves New Treatment for Early Alzheimer’s

The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
What if You Could Go to the Hospital … at Home?

What if You Could Go to the Hospital … at Home?

Hospital-at-home care is an increasingly common option, and it is often a safer one for older adults. But the future of the approach depends on federal action.